Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jan 19;13:1107071. doi: 10.3389/fendo.2022.1107071

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Hui, Liu, Azami, Song, Huang, Xu, Wu, Xie, Jiang, Bian and Sun

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

SLF had a clinical efficacy on improving the liver function and FibroTouch, as well as relieving symptoms of fatigue. ALT, AST, GGT, CAP, LSM and FS-14 was compared in the two groups to evaluate the efficacy of SLF in liver function and FibroTouch, as well as the symptoms of fatigue. (A) Comparison of ALT in the control group and SLF group. (B) Comparison of AST in the control group and SLF group. (C) Comparison of GGT in the control group and SLF group. (D) Comparison of CAP in the control group and SLF group. (E) Comparison of LSM in the control group and SLF group. (F) Comparison of FS-14 in the control group and SLF group. ALT, Alanine transaminase; AST, Aspartate aminotransferase; GGT, Gamma glutamyl transpeptidase; CAP, Controlled attenuation parameter; LSM, Liver stiffness measurement; FS-14, Fatigue scale-14. ns, no significance. *P < 0.05, **P < 0.01 and ***P < 0.001.